Acetylcysteine Injection, Solution
Product Images NDC 25021-812

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Acetylcysteine (NDC 25021-812). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ace0c 0017 01

A logarithmic graph depicting plasma or serum acetaminophen concentration (µg/mL) over hours post-ingestion. It shows two lines labeled with different reference points, indicating toxicity risk thresholds and guidelines for continuing acetylcysteine treatment based on assay values.*

FDA Label Image

Ace0c 0017 02

Chemical structure of acetylcysteine showing the molecular arrangement including an acetyl group, amino group, carboxyl group, and thiol group.*

FDA Label Image

Ace0c 0017 03

Label for Acetylcysteine Injection, 6 grams per 30 mL (200 mg per mL) solution for intravenous use. The label indicates the product is a single-dose vial that must be further diluted before use. Manufactured by Sagent Pharmaceuticals, the label includes storage instructions and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.